News

2nd Annual IBD Research Symposium March 27, 2026

Inflammatory Bowel Disease Center

AGENDA
2nd Annual IBD Research Symposium
March 27, 2026
Eric P. Newman Education Center (EPNEC), Seminar Room B

7:30 am – 8:15 am
8:15 am – 8:30 am

Welcome Breakfast/Sign in
Introductory remarks: Parakkal Deepak and Matthew A. Ciorba

KEYNOTE PRESENTATION


8:30 am – 9:00 am

Postoperative Crohn’s Disease: Understanding who is high risk for disease progression and Recurrence
Mark Silverberg, MD, PhD
Gastroenterology, Department of Medicine, Mt. Sinai/University of Toronto

SESSION 1: IBD Epithelium Pathways to Therapeutics-Part 1
Moderator: Matt Ciorba, MD

9:00 am – 9:15 am

Targeting Epithelium in IBD
Matt Ciorba, MD

9:15 am – 9:30 am

A Novel Epithelial Junction Gene, CGNL1, is Associated with Very Early Onset IBD
Kaiming Ma, Research Technician

9:30 am – 9:45am

Fungal Microbiota and Intestinal Wound Healing
Umang Jain, PhD

9:45 am – 10:00 am

Potassium Ion Channel Flux in Goblet Cells
Vivian Gonzalez-Perez, PhD

10:00 am – 10:15 am

NAD+ regulates gut epithelial cell differentiation
Ta-Chiang Liu, MD, PhD, AGAF

10:15 am – 10:25 am

Discussion led by moderator

10:25 am – 10:35 am

BREAK

SESSION 2: Disease Monitoring in IBD
Moderator: Parakkal Deepak, MBBS, MS

10:35 am – 10:50 am

Improving the Precision of Management in Perianal Crohn’s Disease through Radiomics
Parakkal Deepak, MBBS, MS

10:50 am – 11:05 am

Anti-IL23 Biomarkers of Response to Therapy
Siyan Cao, MD, PhD

11:05 am – 11:20 am

Novel PET Radiotracers Imaging Inflammation-fibrosis Axis
Yongjian Liu, PhD

11:20am – 11:35 am

Application of PET & MR Imaging in Refractory IBD
David Ballard, MD

11:35 am – 11:45 am

Discussion led by moderator

11:45 am -12:00 pm

BREAK/ Lunch

12:00 pm – 12:05 pm

Introduction

KEYNOTE PRESENTATION


12:05 pm – 12:55 pm

Understanding the Role of the Lymphatic System in the Pathogenesis of IBD
Gwendalyn Randolph, PhD
Emil R. Unanue Professor, Department of Pathology & Immunology, WashU Medicine

12: 55 pm – 1:10 pm

Discussion led by moderator

SESSION 3: IBD Immunology Pathways to Therapeutics-Part 2
Moderator: Matt Ciorba, MD

1:10 pm – 1:25 pm

Role of B Cell-derived Lymphotoxin in Crohn’s Disease-associated Cachexia
Quazim Alayo, MD, MSc

1:25 pm – 1:40 pm

Regulation of Intestinal Inflammation by Neuro Enteric Glia
Xue-Yan He, PhD

1:40 pm – 1:55 pm

Applications of Nonlinear Optical Microscopy to Understand IBD Pathogenesis
Janet Sorrells, PhD

1:55 pm – 2:10 pm

Driving Toward Cell-based Therapies in IBD
ZeNan Chang,MD, PhD

2:10 pm – 2:25 pm

Lymphatic Endothelial Cell TNFR1 Mediates Lymphangitis-associated Tertiary Lymphoid Structure Formation
Heather Ruiz, T32 Scholar PhD Candidate

2:25 pm – 2:40 pm

Discussion led by moderator

2:40 pm – 2:55 pm

BREAK

SESSION 4: Novel IBD Therapeutics Strategies: Closer to the Bedside in the Near Future
Moderator: Parakkal Deepak, MBBS, MS

2:55 pm – 3:10 pm

Novel Mouse Models and Therapeutic Targets for Perianal Fistulizing Crohn’s Disease
Xin Yao, MD

3:10 pm – 3:25pm

Thereaputic Relief of ER Stress Treats Colitis
Matthew A. Ciorba, MD

3:25 pm – 3:40 pm

Modulation of Visceral Adipose Tissue Compartment in IBD
Parakkal Deepak, MBBS, MS

3:40 pm – 3:50 pm

Discussion led by moderator

3:50 pm – 4:00 pm

Wrap Up/Closing Remarks

4:00 pm – 5:00 pm

Social Hour

Register for the 2nd Annual IBD Research Symposium